Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Heywood

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|August 18, 2017
Cell surface dynamics and cellular distribution of endogenous FcRnLena D'Hooghe, Andrew D Chalmers, Sam Heywood, et al.
International Journal of Pharmaceutics|February 14, 2017
PEGylation prolongs the pulmonary retention of an anti-IL-17A Fab' antibody fragment after pulmonary delivery in three different speciesDanielle Freches, Harshad P Patil, Maria Machado Franco, et al.
International Journal of Pharmaceutics|July 16, 2013
Production, purification and biological characterization of mono-PEGylated anti-IL-17A antibody fragmentsSalome-Juliette Koussoroplis, Sam Heywood, Catherine Uyttenhove, et al.
The Biochemical Journal|August 9, 2017
IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and designChloe L Stoyle, Paul E Stephens, David P Humphreys, et al.
The Journal of Biological Chemistry|July 22, 2018
The rational design of affinity-attenuated OmCI for the purification of complement C5Alex Macpherson, Xiaofeng Liu, Neesha Dedi, et al.
Mabs|June 18, 2016
Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin Fv domain: An investigation into the correlation between affinity and serum half-lifeRalph Adams, Laura Griffin, Joanne E Compson, et al.
Mabs|August 18, 2016
Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin bindingEmma Davé, Ralph Adams, Oliver Zaccheo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|August 18, 2017
Cell surface dynamics and cellular distribution of endogenous FcRnLena D'Hooghe, Andrew D Chalmers, Sam Heywood, et al.
International Journal of Pharmaceutics|February 14, 2017
PEGylation prolongs the pulmonary retention of an anti-IL-17A Fab' antibody fragment after pulmonary delivery in three different speciesDanielle Freches, Harshad P Patil, Maria Machado Franco, et al.
International Journal of Pharmaceutics|July 16, 2013
Production, purification and biological characterization of mono-PEGylated anti-IL-17A antibody fragmentsSalome-Juliette Koussoroplis, Sam Heywood, Catherine Uyttenhove, et al.
The Biochemical Journal|August 9, 2017
IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and designChloe L Stoyle, Paul E Stephens, David P Humphreys, et al.
The Journal of Biological Chemistry|July 22, 2018
The rational design of affinity-attenuated OmCI for the purification of complement C5Alex Macpherson, Xiaofeng Liu, Neesha Dedi, et al.
Mabs|June 18, 2016
Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin Fv domain: An investigation into the correlation between affinity and serum half-lifeRalph Adams, Laura Griffin, Joanne E Compson, et al.
Mabs|August 18, 2016
Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin bindingEmma Davé, Ralph Adams, Oliver Zaccheo, et al.
Pageof 1